Effectiveness of solifenacin for managing of bladder spasms in patients with urethroplasty

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-17011523

Enrollment

Unknown

Registered

2017-05-30

Start date

2017-06-01

Completion date

Unknown

Last updated

2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder spasm

Interventions

1st group:solifenacin

2nd group:vitamin C

Eligibility

Sex/Gender

Male

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. aged 18 to 45 years; 2. Without a history of open urethral surgery; 3. The patient/family members informed and sign the informed consent;

Exclusion criteria

Exclusion criteria: 1. with a history of severe hypertension; 2. with a history of diabetes; 3. with a history of the blood coagulation dysfunction or anticoagulant drugs; 4. with liver or kidney dysfunction; 5. Patients who can not cooperate with treatment; 6. mental disorder or nerve dysfunction.

Design outcomes

Primary

Measure	Time frame
visual analogue scale;??;time;	—

Countries

China

Contacts

Public ContactXinru Zhang

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

15800558925@163.com+86 15800558925

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026